Stay updated on Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Sign up to get notified when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.

Latest updates to the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUI updates include show/hide glossary toggles and minor label/version changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA minor site revision updated the page to include Revision: v3.3.4 and remove Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now consolidates site information under a general Locations heading, listing Arkansas, California, Florida, Massachusetts, South Carolina, and Virginia. Per-state location sections were removed, and the page revision updated to v3.3.3.SummaryDifference0.7%

- Check71 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedRemoved the temporary notice about government funding and NIH operating status from the page.SummaryDifference0.3%

- Check101 days agoChange DetectedThese changes are minor UI updates and metadata changes that do not modify the study's core details. There were no changes to eligibility criteria, interventions, primary outcomes, or location lists.SummaryDifference0.4%

Stay in the know with updates to Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.